RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > 2020 > 9 > Regulatory obligations beyond the new MDR deadline: A long-term focus

Regulatory obligations beyond the new MDR deadline: A long-term focus

Posted 13 September 2020 | By SAI Global 

Regulatory obligations beyond the new MDR deadline: A long-term focus

Even with the EU MDR transition deadline being pushed back one year until May 2021, the deadline is still fast approaching. Many organizations were stretched thin in their attempt to meet the changes to the vast number of Standards and regulations for the original deadline. While achieving compliance before the new deadline is essential, many companies within the medical device (MedDev) industry may find themselves in trouble in the months following.

Staying focused on the long-term approach

Keeping on top of your regulatory obligations and staying compliant should be a long-term focus. Just as MedDev organizations have devoted specific resources and time into a strategy to meet the short-term deadline of EU MDR, organizations should also prioritize a long-term strategy of maintaining compliance. Meeting these requirements should be a strategy that is “always on”, not intermittent.

Importance of regulatory obligations throughout every step

MedDev companies often require regulatory guidance in departments or development project teams regarding the design, development, evaluation, or marketing of products. Companies also invest in developing regulatory strategies and implementation plans for the preparation and submission of new products. These activities all take place over months, even years, and require strategic effort and dedication to meeting regulatory obligations.

Failure to stay compliant with the relevant Standards (such as the MedDev quality management system Standard ISO 13485:2016 stating requirements for regulatory purposes) and meet the relevant regulatory obligations can have dangerous consequences due to the nature and use of medical devices. For both those working in the MedDev space and the end users, there is no room for error.

As the MedDev industry is inherently high-risk, a comprehensive risk management system must be implemented to guarantee all efforts have been made the minimize risk as much as possible. ISO 14971:2019 is the new edition of a crucial standard in the industry. This standard details the application of risk management for medical devices, and provides guidance on how risk should be assessed, analyzed, monitored, documented and controlled to protect both the end user and the manufacturer. The new edition aligns with the new EU MDR and EU IVDR performance requirements and provides a risk-management framework for the MedDev industry from start to finish, providing a long-term and “always on” strategy that will help your organization meet regulatory obligations.

Regulatory challenges faced in the MedDev industry

In this demanding environment, those handling regulatory affairs face constant challenges. These are, but not limited to:
  • Finding the Standards necessary to meet not only the regulatory obligations of the country being manufactured in, but also of all the countries being exported to
  • Receiving information on changes to Standards and understanding the differences compared to the previous version
  • Collecting all the relevant Standards that are important for a specific product group
  • Staying informed on new regulations as they are published
  • Maintaining reporting on regulatory requirements in an efficient and timely manner
How to stay ahead of your regulatory obligations

Continuing to meet your regulatory obligations means ensuring that your organization is always using up-to-date and current Standards. SAI Global's digital platform i2i can help those in the MedDev space to stay compliant past the short-term focus on the EU MDR deadline. In the lead up to and beyond the May deadline, i2i can help ensure that the MedDev industry meets the relevant regulatory obligations by providing instant alerts when Standards and documents are updated or deleted. It can assist in the time-consuming process of maintaining reporting on regulatory requirements and increase efficiency and safety in the MedDev industry. To stay up to date with Standards and industry insights, join us here.

This article is sponsored and does not reflect the views or opinions of RAPS. The sponsor is solely responsible for the content presented.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.